Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peopleThe Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
- Where
- Hefei, Wuhan
- Age
- 3 years to 70 years
- People
- 9
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06307600 - No phaseTaking peopleA Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
- Where
- Taiyuan
- People
- 45
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT06783816 - Phase 2Taking peopleCAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
- Where
- Tianjin
- Age
- Up to 25 years
- People
- 100
- Run by
- Beijing Yongtai Ruike Biotechnology Company Ltd
See details and how to joinNCT06179524 - Phase 2Not yet taking people in ChinaAvapritinib Maintenance for AML With KIT Mutations
- Where
- Shanghai
- Age
- 14 years to 70 years
- People
- 47
- Run by
- Ruijin Hospital
See details and how to joinNCT06765915 - Phase 2Not yet taking people in ChinaLow-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
- Where
- Chengdu
- Age
- 3 years to 18 years
- People
- 50
- Run by
- West China Hospital
See details and how to joinNCT06763315 - Phase 3Enrolling by invitationFHND9041 Versus Afatinib for Non-small Cell Lung Cancer
- Where
- Beijing
- Age
- 18 months and over
- People
- 350
- Run by
- Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
See details and how to joinNCT06759857 - Phase 1Taking peopleUGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
- Where
- Guangzhou
- Age
- Up to 18 years
- People
- 39
- Run by
- Sun Yat-sen University
See details and how to joinNCT06760117 - No phaseTaking peopleDolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
- Where
- Hefei
- Age
- 2 years to 17 years
- People
- 500
- Run by
- Anhui Provincial Children's Hospital
See details and how to joinNCT06756022 - Phase 1Taking peopleCD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
- Where
- Guangzhou
- Age
- 1 year to 18 years
- People
- 10
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06752785 - No phaseTaking peopleA Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
- Where
- Suzhou
- Age
- Up to 79 years
- People
- 120
- Run by
- Suzhou Municipal Hospital
See details and how to joinNCT06754488 - Early phase 1Taking peopleA Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
- Where
- Chengdu
- Age
- 1 year to 18 years
- People
- 30
- Run by
- The General Hospital of Western Theater Command
See details and how to joinNCT06684639 - No phaseTaking peopleLymph Node Pathologic Grading Strategy
- Where
- Shanghai
- People
- 2,998
- Run by
- Fudan University
See details and how to joinNCT06745830 - Phase 2Taking peopleVHAG in Treating R/R T-ALL/LBL
- Where
- Hangzhou
- Age
- 14 years to 74 years
- People
- 50
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742463 - Phase 2Taking peopleBlinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
- Where
- Hangzhou
- Age
- 15 years to 59 years
- People
- 20
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742515 - Phase 1/2Taking peopleCD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
- Where
- Wuhan
- Age
- 3 years to 75 years
- People
- 80
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06735495 - Phase 1Taking peopleRD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
- Where
- Wuhan
- Age
- 3 years to 70 years
- People
- 10
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06732492 - No phaseTaking peopleThe Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
- Where
- Shanghai
- Age
- 16 years to 80 years
- People
- 40
- Run by
- Ruijin Hospital
See details and how to joinNCT06730529 - No phaseTaking peopleZero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
- Where
- Shanghai
- Age
- 15 years to 80 years
- People
- 80
- Run by
- RenJi Hospital
See details and how to joinNCT06715878 - No phaseTaking peopleAI Recognition of Important Structures in Otolaryngological Surgery
- Where
- Guangzhou
- Age
- 6 months to 100 years
- People
- 1,000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06726551 - No phaseTaking peopleThe Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
- Where
- Guangzhou
- People
- 100
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06727162 - No phaseTaking peopleFour Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
- Where
- Beijing
- People
- 171
- Run by
- Shu Wang
See details and how to joinNCT06722599 - No phaseTaking peopleChemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
- Where
- Beijing
- People
- 2,916
- Run by
- Shu Wang
See details and how to joinNCT06722612 - Phase 1/2Taking peopleCD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors
- Where
- Wuhan
- Age
- 3 years to 75 years
- People
- 80
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06720324 - No phaseTaking peopleRegistry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)
- Where
- Shanghai
- Age
- 14 years and over
- People
- 500
- Run by
- Ruijin Hospital
See details and how to joinNCT06534463 - Phase 2Taking peopleTrilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
- Where
- Beijing
- Age
- 14 years to 70 years
- People
- 50
- Run by
- Peking University People's Hospital
See details and how to joinNCT06714383